Baltimore, Md.; Omaha, Neb.; Chicago, Ill.; Raleigh, N.C.; and Boston, Mass.
From the Department of Plastic and Reconstructive Surgery, The Johns Hopkins Hospital; the Department of General Surgery, University of Nebraska Medical Center, and Creighton School of Medicine; Rush Medical College; the Division of Plastic, Oral, and Maxillofacial Surgery, Duke Univer sity Hospital; Boston University School of Public Health; and the Division of Plastic and Reconstructive Surgery, Massachusetts General Hospital.
Plast Reconstr Surg. 2018 Jun;141(6):1592-1599. doi: 10.1097/PRS.0000000000004380.
The purpose of this study was to analyze the frequency and nature of self-reported conflict-of-interest disclosures in the plastic surgery literature and to compare these findings to the Physician Payments Sunshine Act database.
All articles published from August of 2013 through December of 2013 in four major plastic surgery journals were analyzed. For every publication, the conflict-of-interest disclosure statement for each investigator was reviewed. These statements were then compared to transactions of value for each investigator as reported by biomedical companies in the Sunshine Act database. An analysis was performed to identify and characterize specific factors associated with conflict-of-interest disclosures.
A total of 1002 independent investigators/authors were identified. Of these, 90 investigators (9 percent) self-reported a conflict of interest. In contrast, a total of 428 authors (42.7 percent) were found to have received transactions of value from a biomedical company according to the Sunshine Act database. Conversely, a total of 22 authors (2.2 percent) self-reported a conflict of interest but were not found to have received transactions of value in the Sunshine Act database. Our analysis found that (1) academic investigators, (2) transactions of value in excess of $500, and (3) publishing articles related to the sponsoring biomedical company were all statistically associated with reporting conflicts of interest (p < 0.0001).
Discordance exists between investigator/authors self-reporting in scientific journals and the government-mandated reporting of conflicts of interest by industry. Factors associated with conflict-of-interest disclosure include academic status, transaction amount, and article content related to the sponsoring biomedical company.
本研究旨在分析整形外科学文献中自我报告的利益冲突披露的频率和性质,并将这些发现与医师薪酬阳光法案数据库进行比较。
分析了 2013 年 8 月至 12 月在四大整形外科学杂志上发表的所有文章。对于每篇出版物,都审查了每位研究人员的利益冲突披露声明。然后将这些声明与阳光法案数据库中生物医学公司报告的每位研究人员的价值交易进行比较。进行了一项分析,以确定和描述与利益冲突披露相关的具体因素。
共确定了 1002 位独立的研究人员/作者。其中,90 位研究人员(9%)自我报告存在利益冲突。相比之下,根据阳光法案数据库,共有 428 位作者(42.7%)发现从生物医学公司获得了价值交易。相反,共有 22 位作者(2.2%)自我报告存在利益冲突,但在阳光法案数据库中未发现有价值交易。我们的分析发现,(1)学术研究人员,(2)超过 500 美元的价值交易,以及(3)与赞助生物医学公司相关的文章出版,都与报告利益冲突具有统计学相关性(p < 0.0001)。
研究人员/作者在科学期刊上的自我报告与行业强制报告利益冲突之间存在差异。利益冲突披露的相关因素包括学术地位、交易金额以及与赞助生物医学公司相关的文章内容。